During the past decade, Southeastern Retina Associates, P.C. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Retina Associates, P.C." #1 sponsor was "Jaeb Center for Health Research" with 19 trials, followed by "Kodiak Sciences Inc" with 5 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "National Eye Institute (NEI)" with 2 trials sponsored and "Neurotech Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Retina Associates, P.C." #1 collaborator was "National Eye Institute (NEI)" with 18 trials as a collaborator, "National Institutes of Health (NIH)" with 7 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Allergan" with 4 trials as a collaborator and "Regeneron Pharmaceuticals" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Retina Associates, P.C." are "Diabetic Macular Edema" (13 trials), "Diabetic Retinopathy" (7 trials), "Proliferative Diabetic Retinopathy" (4 trials), "Vitreous Hemorrhage" (3 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Southeastern Retina Associates, P.C." in a lesser frequency.

Most popular intervention types in "Southeastern Retina Associates, P.C." are "Drug" (29 trials), "Other" (9 trials), "Procedure" (9 trials), "Device" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "KSI-301" (5 trials), "Aflibercept" (4 trials), "Sham Procedure" (4 trials), "Ranibizumab" (3 trials) and "Sham" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Retina Associates, P.C." are 35 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Retina Associates, P.C.". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Southeastern Retina Associates, P.C., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Retina Associates, P.C., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".